Kataoka, Y. Thymus and activation-regulated chemokine (CCL17) as a clinical biomarker in atopic dermatitis: Significance and limitations in the new treatment era. Frontiers Media S.A.
Chicago Style (17th ed.) CitationKataoka, Yoko. Thymus and Activation-regulated Chemokine (CCL17) as a Clinical Biomarker in Atopic Dermatitis: Significance and Limitations in the New Treatment Era. Frontiers Media S.A.
MLA (9th ed.) CitationKataoka, Yoko. Thymus and Activation-regulated Chemokine (CCL17) as a Clinical Biomarker in Atopic Dermatitis: Significance and Limitations in the New Treatment Era. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.